Abstract
A polypeptide isolated by the hydrolysis of growth hormone, studied in five patients with diabetes mellitus, has been shown able to produce hypoglycaemia, presumably by modifying the anti-insulin action of pituitary growth hormone. Possibly this substance may be suitable for treating cases of insulin resistance or when a circulating inhibitor of glucose uptake is present.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BORNSTEIN J., HYDE D. Insulin antagonists in blood of juvenile diabetics with arterial disease. Diabetes. 1959 Mar-Apr;8(2):92–93. doi: 10.2337/diab.8.2.92. [DOI] [PubMed] [Google Scholar]
- Bornstein J., Armstrong J. M., Jones M. D. The effect of a growth hormone fraction on the activities of glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta. 1968 Feb 1;156(1):38–43. doi: 10.1016/0304-4165(68)90101-3. [DOI] [PubMed] [Google Scholar]
- Bornstein J., Krahl M. E., Marshall L. B., Gould M. K., Armstrong J. M. Pituitary peptides with direct action on the metabolism of carbohydates and fatty acids. Biochim Biophys Acta. 1968 Feb 1;156(1):31–37. doi: 10.1016/0304-4165(68)90100-1. [DOI] [PubMed] [Google Scholar]